deferiprone and razoxane

deferiprone has been researched along with razoxane in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clarke, JJ; Dunkel, VC; San, RH; Seifried, HE; Whittaker, P1
Barnabé, N; Hasinoff, BB; Venkataram, S; Zastre, JA1

Other Studies

2 other study(ies) available for deferiprone and razoxane

ArticleYear
Genotoxicity of iron chelators in L5178Y mouse lymphoma cells.
    Environmental and molecular mutagenesis, 2001, Volume: 38, Issue:4

    Topics: Animals; Deferiprone; Edetic Acid; Iron Chelating Agents; Lymphoma; Mice; Mutagenicity Tests; Phenanthrolines; Pyridones; Razoxane; Tumor Cells, Cultured

2001
Deferiprone protects against doxorubicin-induced myocyte cytotoxicity.
    Free radical biology & medicine, 2002, Jul-15, Volume: 33, Issue:2

    Topics: Animals; Animals, Newborn; Antineoplastic Agents; Cell Survival; Cells, Cultured; Deferiprone; Doxorubicin; Electron Spin Resonance Spectroscopy; Fluoresceins; Free Radicals; Indicators and Reagents; Iron; Iron Chelating Agents; L-Lactate Dehydrogenase; Myocytes, Cardiac; Oxidation-Reduction; Pyridones; Rats; Rats, Sprague-Dawley; Razoxane

2002